Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Duolip

Known as: Merckle brand of etofyllinclofibrate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
BACKGROUND Duolip forte (ethophyllinclofibrate) is a lipid lowering drug, the effect of which was not yet adequately verified in… Expand
1994
1994
BACKGROUND Insulin resistance and hypertriacylglycerolaemia are part of the X syndrome and are supposed to be interrelated. The… Expand
1993
1993
The authors investigated in 29 patients with familial hyperlipoproteinaemia the effect of fibrate treatment (Duolip forte… Expand
1993
1993
Duolip forte (ethophylline clofibrate, tablets à 500 mg) produced by Merckle Austria was administered to 20 patients with… Expand
1986
1986
1-(7-Theophyllinyl)-2-ethyl-[2-(p-chlorophenoxy)-isobutyrate] (etofylline clofibrate, theofibrate, Duolip) was shown to possess… Expand
1983
1983
  • R. Scherhag
  • Fortschritte der Medizin
  • 1983
  • Corpus ID: 39248578
During an 8-months treatment period the effect of Duolip on serum uric acid in 112 patients with hyperlipidemia was studied. In… Expand
1980
1980
The biopharmaceutic criteria of Duolip and its active principle, 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2… Expand
1980
1980
1-(Theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate, ML 1024, Duolip) was investigated… Expand
1980
1980
1-(Theophyllin-7yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate, ML 1024, Duolip) was shown to be a… Expand
1980
1980
Esters of phenoxyacetic acids and oxyalkyltheophyllines were prepared as potential antihyperlipaemics. The basic idea was to… Expand